| Net Cash Provided by (Used in) Operating Activities |
$278,992,000 |
USD |
61% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$243,239,000 |
USD |
-20% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
1,152,100,000 |
shares |
-15% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
465,916,352 |
shares |
7.5% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$35,753,000 |
USD |
|
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$86,541,000 |
USD |
52% |
Q3 2025 |
Q1 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$26,336,000 |
USD |
-28% |
Q3 2025 |
Q1 2026 |
| Additional Paid in Capital |
$4,272,510,000 |
USD |
0.53% |
Q3 2025 |
Q1 2026 |
| Interest Expense |
$39,841,000 |
USD |
6.2% |
Q1 2024 |
Q3 2024 |